AR008620A1 - Vacuna viva recombinante, fragmento de adn y virus iltv que la componen - Google Patents
Vacuna viva recombinante, fragmento de adn y virus iltv que la componenInfo
- Publication number
- AR008620A1 AR008620A1 ARP970102799A ARP970102799A AR008620A1 AR 008620 A1 AR008620 A1 AR 008620A1 AR P970102799 A ARP970102799 A AR P970102799A AR P970102799 A ARP970102799 A AR P970102799A AR 008620 A1 AR008620 A1 AR 008620A1
- Authority
- AR
- Argentina
- Prior art keywords
- virus
- vaccine
- make
- dna fragment
- iltv
- Prior art date
Links
- 241000701063 Gallid alphaherpesvirus 1 Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 3
- 125000003729 nucleotide group Chemical group 0.000 abstract 3
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 2
- 241000711450 Infectious bronchitis virus Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 108091026890 Coding region Proteins 0.000 abstract 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 241000702626 Infectious bursal disease virus Species 0.000 abstract 1
- 241000711902 Pneumovirus Species 0.000 abstract 1
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9608243A FR2750866B1 (fr) | 1996-06-27 | 1996-06-27 | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008620A1 true AR008620A1 (es) | 2000-02-09 |
Family
ID=9493649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102799A AR008620A1 (es) | 1996-06-27 | 1997-06-25 | Vacuna viva recombinante, fragmento de adn y virus iltv que la componen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6153199A (enExample) |
| EP (1) | EP0914458A1 (enExample) |
| JP (1) | JP2000512844A (enExample) |
| AR (1) | AR008620A1 (enExample) |
| AU (1) | AU739374B2 (enExample) |
| CO (1) | CO4700303A1 (enExample) |
| FR (1) | FR2750866B1 (enExample) |
| ID (1) | ID18351A (enExample) |
| MA (1) | MA24222A1 (enExample) |
| PE (1) | PE52599A1 (enExample) |
| TN (1) | TNSN97109A1 (enExample) |
| WO (1) | WO1997049826A1 (enExample) |
| ZA (1) | ZA975618B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6913751B2 (en) | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
| EP1026246B1 (en) * | 1997-10-03 | 2006-11-29 | Zeon Corporation | Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| AR031405A1 (es) * | 2000-11-21 | 2003-09-24 | Wyeth Corp | Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo |
| JP2002356441A (ja) * | 2001-03-15 | 2002-12-13 | Akzo Nobel Nv | 組換え伝染性喉頭気管炎ウイルスワクチン |
| US7314715B2 (en) * | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
| US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
| MXPA04004634A (es) | 2001-11-16 | 2004-08-12 | Idec Pharma Corp | Expresion policistronica de anticuerpos. |
| EP1606419A1 (en) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| WO2005049794A2 (en) | 2003-11-13 | 2005-06-02 | University Of Georgia Research Foundation, Inc. | Methods of characterizing infectious bursal disease virus |
| WO2005112544A2 (en) | 2004-02-19 | 2005-12-01 | The Governors Of The University Of Alberta | Leptin promoter polymorphisms and uses thereof |
| RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| EP3147296A1 (en) | 2005-11-14 | 2017-03-29 | Merial, Inc. | Gene therapy for renal failure |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| EP2414386B1 (en) | 2009-04-03 | 2016-01-27 | Merial Limited | Newcastle disease virus vectored avian vaccines |
| ES2380289T3 (es) | 2009-11-30 | 2012-05-10 | United Cancer Research Institute | Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer |
| US10633667B2 (en) | 2009-12-28 | 2020-04-28 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant NDV antigen and uses thereof |
| BR112013002525A2 (pt) * | 2010-08-02 | 2016-05-31 | Univ Georgia | vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo |
| EP2611460B1 (en) | 2010-08-31 | 2016-10-05 | Merial, Inc. | Newcastle disease virus vectored herpesvirus vaccines |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| EP2694678A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
| WO2012149038A1 (en) | 2011-04-25 | 2012-11-01 | Advanced Bioscience Laboratories, Inc. | Truncated hiv envelope proteins (env), methods and compositions related thereto |
| CA2837375C (en) | 2011-06-01 | 2019-07-16 | Merial Limited | Needle-free administration of prrsv vaccines |
| MX350096B (es) | 2011-08-12 | 2017-08-25 | Merial Inc | Preservación asistida con vacío de productos biológicos, en particular de vacunas. |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| EP2922465A4 (en) | 2012-11-21 | 2016-07-06 | Cardiomems Inc | DEVICES, SYSTEMS AND METHODS FOR ASSESSING AND TREATING PULMONARY ARTERIAL HYPERTENSION (PAH) |
| HK1216006A1 (zh) | 2013-03-12 | 2016-10-07 | Boehringer Ingelheim Animal Health USA Inc. | 反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法 |
| US9198908B2 (en) | 2013-03-15 | 2015-12-01 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux Ii”) | Methods for the treatment of cardiovascular conditions |
| EP2845904A1 (en) * | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
| WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| ES3050936T3 (en) | 2015-06-23 | 2025-12-23 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0434721B1 (en) * | 1988-09-13 | 2000-03-15 | Merial | Viral nucleotide sequences |
| WO1992003554A1 (en) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Infectious laryngotracheitis virus vaccine |
| WO1993025655A1 (en) * | 1992-06-12 | 1993-12-23 | Genencor International, Inc. | Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric |
| AU2946395A (en) * | 1994-06-30 | 1996-01-25 | Board of Regents of the University of Illinois, The | Recombinant infectious laryngotracheitis virus and vaccine |
| FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
| CA2216139C (en) * | 1995-03-23 | 2013-01-08 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
-
1996
- 1996-06-27 FR FR9608243A patent/FR2750866B1/fr not_active Expired - Lifetime
-
1997
- 1997-06-23 MA MA24675A patent/MA24222A1/fr unknown
- 1997-06-25 TN TNTNSN97109A patent/TNSN97109A1/fr unknown
- 1997-06-25 AR ARP970102799A patent/AR008620A1/es unknown
- 1997-06-25 ZA ZA975618A patent/ZA975618B/xx unknown
- 1997-06-25 EP EP97930591A patent/EP0914458A1/fr not_active Withdrawn
- 1997-06-25 WO PCT/FR1997/001138 patent/WO1997049826A1/fr not_active Ceased
- 1997-06-25 AU AU34487/97A patent/AU739374B2/en not_active Expired
- 1997-06-25 JP JP10502456A patent/JP2000512844A/ja active Pending
- 1997-06-26 ID IDP972222A patent/ID18351A/id unknown
- 1997-06-27 PE PE1997000548A patent/PE52599A1/es not_active Application Discontinuation
- 1997-06-27 CO CO97036155A patent/CO4700303A1/es unknown
-
1998
- 1998-12-23 US US09/219,932 patent/US6153199A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3448797A (en) | 1998-01-14 |
| CO4700303A1 (es) | 1998-12-29 |
| FR2750866B1 (fr) | 1998-11-27 |
| US6153199A (en) | 2000-11-28 |
| AU739374B2 (en) | 2001-10-11 |
| WO1997049826A1 (fr) | 1997-12-31 |
| JP2000512844A (ja) | 2000-10-03 |
| MA24222A1 (fr) | 1997-12-31 |
| EP0914458A1 (fr) | 1999-05-12 |
| FR2750866A1 (fr) | 1998-01-16 |
| ID18351A (id) | 1998-04-02 |
| TNSN97109A1 (fr) | 2005-03-15 |
| ZA975618B (en) | 1998-12-28 |
| PE52599A1 (es) | 1999-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR008620A1 (es) | Vacuna viva recombinante, fragmento de adn y virus iltv que la componen | |
| Singh et al. | Re-emerging fowlpox: evaluation of isolates from vaccinated flocks | |
| US10245315B2 (en) | Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species | |
| CO4650230A1 (es) | Vacuna viva recombinante aviaria, utilizando como vector el virus de la laringotraqueitis infecciosa aviaria | |
| HUP9902790A2 (hu) | Madarakban alkalmazható polinukleotid-vakcinakészítmények | |
| CO4650231A1 (es) | Vacuna viva recombinante aviaria que utiliza como vector el virus de laringotraqueitis infecciosa aviaria | |
| AR020091A1 (es) | Adnc de paramyxovirus aviar (particularmente virus de la enfermedad de newcastle), arn, metodo para generar copias de virus infeccioso de paramyxovirusaviar, copia de virus infeccioso, vacuna que comprende dicho virus, vacuna viva, metodo para distinguir animales no vacunados o animales vacunados, y | |
| RU2019136150A (ru) | Вакцины против рекомбинантного герпесвируса gallid 3, кодирующие гетерологичные антигены птичьего патогена | |
| EP1298139A3 (en) | Avian herpes virus-based recombinant infectious bursal disease vaccine | |
| CA2166367A1 (en) | Live recombinant avian vaccine using an avian herpesvirus as vector | |
| AR037062A1 (es) | Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adn | |
| JP2006348044A (ja) | 鳥類ヘルペスウイルスをベースとした組換型鳥類用生ワクチン、特にガンボロ病用ワクチン | |
| AU729518B2 (en) | Recombinant fowlpox viruses and uses thereof | |
| CA2478081A1 (en) | Multiple and multivalent dna vaccines in ovo | |
| ECSP972164A (es) | Vacunas de uso aviario a base de virus de laringotraqueitis infecciosa | |
| EP0365349A1 (en) | Avipox virus promoter | |
| RU2025108095A (ru) | Вакцины для домашней птицы и способы защиты домашней птицы | |
| JPH04506901A (ja) | トリポックスウイルスプロモーター | |
| RU2021120823A (ru) | Рекомбинантные вирусы и их применение | |
| NZ785701A (en) | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof | |
| TH2101003714A (th) | ไวรัสชนิดรีคอมบิแนนท์และการใช้ไวรัสนั้น | |
| RU2021120675A (ru) | Рекомбинантные вирусы птичьего герпеса, содержащие несколько чужеродных генов | |
| NZ785701B2 (en) | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof | |
| RU99103126A (ru) | Формула полинуклеотидной вакцины для птиц | |
| Audonnet et al. | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease |